
Izotropic Corporation
Izotropic Corporation (IZO.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
izo.cn · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Izotropic CorporationYou IZO.CN | $19M | N/A | — | — |
DIAGNOS Inc. ADK.V | $22M | N/A | — | -$0.05 |
Avicanna Inc. AVCN.TO | $14M | N/A | — | -$0.02 |
BriaCell Therapeutics Corp. BCT.TO | $8M | N/A | — | -$62.95 |
BioMark Diagnostics Inc. BUX.CN | $59M | N/A | — | -$0.02 |
Charlotte's Web Holdings, Inc. CWEB.TO | $92M | N/A | — | -$0.19 |
Gemina Laboratories Ltd. GLAB.CN | $5M | N/A | — | -$0.06 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Izotropic Corporation (IZO.CN) measures how much investors pay for each dollar of the company's trailing earnings. IZO.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.28 by its TTM earnings per share of —.
Frequently asked questions
IZO.CN pe ratio · 6 questionsIZO.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.28 and TTM EPS of —. Data sourced from Financial Modeling Prep via IZO.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Izotropic Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10